Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating chemotherapy and radiation therapy with or without panitumumab after surgery for high-risk advanced head and neck cancers has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer
• Laryngeal Cancer
• Oral Cavity Cancer
• Oropharyngeal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Head and Neck Cancer | Phase 3 | Status: WITHDRAWN